What is key point 1 about "Amberjack funds sell Innovex (INVX) shares worth $162.6 million"?

Amberjack Capital Partners sold 6.6 million shares of Innovex for $162.6 million

What is key point 3 about "Amberjack funds sell Innovex (INVX) shares worth $162.6 million"?

Innovex reported mixed Q4 results with revenue beating estimates but earnings falling short

What is key point 4 about "Amberjack funds sell Innovex (INVX) shares worth $162.6 million"?

Amberjack affiliates announced a public offering of additional 5.75 million shares

2/28/2026 | USA | economy | ✓ Verified - investing.com

Amberjack funds sell Innovex (INVX) shares worth $162.6 million

#Amberjack Capital Partners #Innovex International #Share Sales #NASDAQ #Q4 Financial Results #Public Offering #Investment Portfolio

📌 Key Takeaways

Amberjack Capital Partners sold 6.6 million shares of Innovex for $162.6 million
Despite sales, Amberjack entities remain significant shareholders of Innovex
Innovex reported mixed Q4 results with revenue beating estimates but earnings falling short
Amberjack affiliates announced a public offering of additional 5.75 million shares

📖 Full Retelling

Amberjack Capital Partners and affiliated entities sold 6,620,497 shares of Innovex International, Inc. (NASDAQ:INVX) on February 27, 2026, for approximately $162.6 million as part of their investment portfolio management. The transactions were executed at $24.5913 per share and involved multiple Amberjack entities including Amberjack Capital Fund II, L.P., which sold 4,902,244 shares, and Innovex Co-Invest Fund II, L.P., which sold 1,144,635 shares. Despite these substantial sales, Amberjack entities remain significant shareholders, with Amberjack Capital Fund II, L.P. still holding 16,871,374 shares and Innovex Co-Invest Fund II, L.P. holding 3,939,330 shares post-transaction. The stock has shown strong performance, climbing to $26.35 and reflecting a 53% gain over the past six months and a 44% return over the past year. In other recent developments, Innovex International reported its fourth-quarter financial results, showing mixed performance. The company posted adjusted earnings per share of $0.20, falling short of the analyst consensus of $0.29. However, Innovex's revenue reached $273.6 million, surpassing the $239.47 million estimate and marking a 9% increase from the same quarter last year. This revenue represented a 14% sequential rise from the previous quarter, indicating positive growth despite the earnings miss. Additionally, certain affiliates of Amberjack Capital Partners, L.P. announced a public offering of 5,750,000 shares of Innovex's common stock. The selling stockholders plan to grant underwriters a 30-day option to purchase up to 862,500 additional shares. Notably, Innovex will not sell any shares in this offering and will not receive any proceeds from the sale, as these are shares held by existing stockholders.

🏷️ Themes

Investment Transactions, Financial Performance, Stock Market Activity

📚 Related People & Topics

Nasdaq

American stock exchange

Nasdaq Stock Market (National Association of Securities Dealers Automated Quotations) is an American stock exchange, the second-largest by market cap on the list of stock exchanges, and the first fully electronic stock market. The exchange is based in Manhattan, New York City, and is among the most ...

View Profile → Wikipedia ↗

Entity Intersection Graph

Connections for Nasdaq:

🏢 Nvidia 6 shared

🌐 Insider trading 6 shared

🌐 SEC filing 6 shared

🌐 Restricted stock 2 shared

🌐 Gold as an investment 2 shared

View full profile

Deep Analysis

Why It Matters

Amberjack funds' significant sale of Innovex shares represents a notable shift in investment strategy for these funds and could influence Innovex's stock price. The transaction highlights potential concerns or profit-taking related to Innovex's future prospects, particularly given the mixed financial results recently reported.

Context & Background

Amberjack Capital Partners is an investment firm.
Innovex International Inc. is a company in the pharmaceutical sector.
The stock market experienced volatility in late 2025 due to geopolitical and economic factors.

What Happens Next

The impact of this large sale on Innovex's stock price will be closely watched by investors. Future developments may include further sales by Amberjack funds or changes in Innovex's business operations based on market feedback.

Frequently Asked Questions

What is Innovex International Inc.?

Innovex International Inc. is a pharmaceutical company.

Who is Amberjack Capital Partners?

Amberjack Capital Partners is an investment firm that made the sale of Innovex shares.

What was the reason for the sale?

The article does not explicitly state the reason, but it could be due to profit-taking or concerns about future performance.

How much did Amberjack funds sell?

Amberjack funds sold approximately $162.6 million worth of Innovex shares.

Original Source

              try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Wall Street posts worst month since March amid geopolitics, trade, and AI fears OpenAI hits $730B valuation as Amazon, NVIDIA, and SoftBank inject $110B Gold prices climb, with spot gold set for a monthly gain of more than 8% Where Bernstein sees gold prices ending the decade after latest update (South Africa Philippines Nigeria) Amberjack funds sell Innovex shares worth $162.6 million By Investing.com Insider Trading Published 02/27/2026, 08:25 PM Amberjack funds sell Innovex shares worth $162.6 million 0 INVX -1.09% Amberjack Capital Partners and affiliated entities sold 6,620,497 shares of Innovex International, Inc. NASDAQ:INVX common stock on February 27, 2026. The sales, executed at a price of $24.5913 per share, totaled approximately $162.6 million. The stock has since climbed to $26.35, reflecting a strong 53% gain over the past six months and a 44% return over the past year. The sales were conducted by several entities including Amberjack Capital Fund II, L.P. which sold 4,902,244 shares, Innovex Co-Invest Fund II, L.P. which sold 1,144,635 shares, Innovex Co-Invest Fund, L.P. which sold 271,279 shares, Intervale Capital Fund II, L.P. which sold 234,009 shares, Intervale Capital Fund III, L.P. which sold 60,217 shares and Intervale Capital Fund II-A, L.P. which sold 116 shares. Following the transactions, Amberjack Capital Fund II, L.P. holds 16,871,374 shares and Innovex Co-Invest Fund II, L.P. holds 3,939,330 shares, Innovex Co-Invest Fund, L.P. holds 933,624 shares, Intervale Capital Fund II, L.P. holds 805,355 shares, Intervale Capital Fund III, L.P. holds 207,240 shares and Intervale Capital Fund II-A, L.P. holds 399 shares of Innovex International , Inc. Jason Turowsky, Managing Partner of Amberjack Management, LLC, is associated with these transactions. In other recent news, Innovex International Inc. reported its fourth-quarter financial results, revealing a mixed performance. The company pos...
            

Read full article at source

Source

investing.com